Standard TSH reference ranges flag overt thyroid disease, not optimal function. This article explains where the narrower longevity-medicine target ranges come from, what the underlying evidence actually shows, and where the evidence stops short of proving that treating toward a tighter number improves outcomes.
A guide to TSH testing: who needs it, what normal and abnormal results mean, when to retest, and how thyroid-stimulating hormone guides treatment decisions for hypothyroidism and hyperthyroidism.
Compare at-home UACR test kits with lab accuracy. Normal is under 30 mg/g; longevity-focused clinicians target under 10 mg/g. See collection steps and thresholds.
UACR 39 mg/g falls in the microalbuminuria range (30-300), above the normal <30 cutoff and well above the optimal <10 target. See interpretation by age decade.
Learn what your urine albumin/creatinine ratio (uACR) means, what the normal range is, and exactly how each result category triggers different clinical decisions for diabetes, hypertension, and kidney disease management.
Learn what your urine albumin/creatinine ratio means, what a normal range looks like, and which diet, medication, and lifestyle strategies have the strongest clinical evidence for lowering it.
UACR categories, meaningful progression thresholds, and KDIGO 2024 recheck intervals explained, grouped by normal, A2, and A3 albuminuria levels.
A decade-by-decade guide to ACTH normal ranges, optimal values, and clinical interpretation for adrenal function, HPA axis health, and longevity medicine.
What adiponectin levels actually predict longevity outcomes, how to interpret your lab result against research-backed target ranges, and when to act on a low value.
A guide to aldosterone normal ranges, longevity-medicine optimal targets, primary aldosteronism screening, and how to interpret your results in the context of cardiovascular and metabolic health.
ACE inhibitors, ARBs, diuretics, beta-blockers and hormonal therapy skew ARR results. See which drugs raise or suppress aldosterone before testing.
What alkaline phosphatase levels predict the longest, healthiest life? A guide to optimal ALP ranges, isoenzyme interpretation, and evidence-based longevity targets.
Intestinal ALP peaks 2 to 4 hours after a fatty meal, especially in blood groups B and O. Reference range is 44-147 IU/L; longevity target is 50-100 IU/L.
Does fasting change your ANA result? Learn how nutrition, fasting status, supplements, and diet affect antinuclear antibody testing, what a normal ANA range looks like, and how to get the most accurate result.
ApoB is a more accurate cardiovascular risk predictor than LDL-C. Learn what optimal ApoB levels look like in longevity medicine, what major trials show, and what target ranges leading guidelines recommend.
Does exercise lower ApoB? A detailed clinical review of how aerobic training, resistance work, and combined protocols affect ApoB levels, with dose thresholds, timelines, and what to expect from your next lipid panel.
A decade-by-decade clinical guide to AST (aspartate aminotransferase) interpretation, covering normal ranges, optimal targets, the AST/ALT ratio, and when to act on an abnormal result.
Aspartate aminotransferase (AST) reference ranges flag disease, but longevity medicine asks a sharper question: what AST level is associated with the lowest all-cause mortality and best metabolic health? This guide covers the evidence, the AST/ALT ratio, and the numbers your clinician should be targeting.
AST can rise 2 to 5x normal after intense training and usually returns to baseline within 72 hours. Learn the AST/ALT ratio that separates muscle from liver causes.
How to read your 24-hour ambulatory blood pressure report: normal ranges, dipper status, rate-of-change thresholds, and what masked hypertension means for your cardiovascular risk.
Does exercise raise or lower your coronary artery calcium score? Evidence from clinical trials, society guidelines, and longevity medicine on how training impacts CAC scores and cardiovascular risk.
How to read CGM data at every age, what target ranges come from guidelines versus clinical practice patterns, and a decision framework for choosing the right target tier based on age-related hypoglycemia risk.
What CGM numbers actually predict long-term health, and what is still unproven. Evidence-based context for time-in-range, mean glucose, glycemic variability, and fasting glucose in non-diabetic adults using CGM for longevity purposes.
How to read and act on coronary CT angiogram results at every age, from your 30s through your 70s and beyond. Covers normal ranges, plaque burden scoring, and evidence-based treatment thresholds.
What do your coronary CT angiogram results mean for longevity? Learn the optimal CCTA target ranges, plaque categories, and clinical thresholds used in preventive cardiology and longevity medicine.
How sex hormones and the menstrual cycle affect DEXA body composition results, what normal and optimal ranges look like for men and women, and why these differences matter for GLP-1 lean mass tracking.
A specific look at DEXA T-scores and Z-scores, the WHO osteoporosis classification, longevity-medicine target ranges above the diagnostic floor, and how FRAX and T-score together shape treatment decisions.
Learn how to interpret DEXA bone density rate-of-change scores, understand T-scores and Z-scores, identify when alendronate or other interventions are warranted, and see what longevity-medicine guidelines say about optimal bone mineral density targets.
A clinical guide to how medications, hormones, and supplements shift DHEA-S levels, what the optimal range looks like by age and sex, and how to interpret results in the context of HRT, corticosteroids, and GLP-1 therapy.
Learn exactly how nutrition, fasting, caffeine, supplements, and meal timing affect DUTCH test results, including cortisol, estrogen metabolites, androgens, and organic acids. guidance with primary-source citations.
Learn how diet, protein intake, fasting, and hydration shift eGFR readings, what the optimal eGFR range is, and how clinicians interpret results before prescribing GLP-1s, metformin, or TRT.
How aerobic training, resistance exercise, and high-intensity intervals affect eGFR values, what the optimal eGFR range looks like, and how to interpret post-exercise dips before dosing GLP-1s, metformin, or TRT.
What is the optimal epigenetic age (DNAm) range? A clinically sourced guide to GrimAge, Horvath, and DunedinPACE targets, interpretation, and interventions backed by primary literature.
The age-adjusted ESR upper limit formula (age+10)/2 for women is discussed alongside how to track ESR trends over time, not just single values against fixed ranges.
Estrone (E1) normal ranges, optimal longevity-medicine targets, and clinical interpretation for postmenopausal women and aging men, with primary-source citations.
Understand fasting triglyceride results, medicines that raise or lower them, cardiovascular trial findings and the follow-up questions that guide treatment.
Why ferritin reference ranges differ by sex, how menstrual cycles and hormones shift iron stores, and what optimal ferritin actually means for hair loss, restless legs, thyroid function, and longevity.
How diet, fasting, inflammation, and lifestyle choices raise or lower ferritin, and what the optimal range looks like for iron stores, hair loss, restless legs, and longevity medicine.
Evidence-based optimal ranges for serum folate and RBC folate in longevity medicine, covering MTHFR, methylation, cardiovascular risk, and cognitive health with primary-source citations throughout.
A guide to Free T3 normal ranges, longevity-medicine target ranges, how Free T3 differs from TSH and Free T4, and when optimization matters for long-term health.
Evidence-based guide to Free T4 normal ranges, longevity-medicine targets, and clinical interpretation. Includes primary literature citations, society guidelines, and a decision framework.
A guide to galectin-3 normal ranges, optimal longevity targets, cardiac fibrosis risk, and how to interpret your result in the context of heart failure prognosis and biological aging.
How diet, fasting and supplements affect urinary organic acids, with Genova collection guidance, vitamin-marker interpretation and practical follow-up.
What are optimal GIP (gastric inhibitory polypeptide) levels for longevity medicine? Understand normal ranges, tirzepatide mechanisms, and clinical target thresholds backed by primary literature.
GlycoMark (1,5-AG) drops sharply with SGLT-2 inhibitors and can fall after GLP-1 agonists. Learn which drugs alter 1,5-anhydroglucitol, how to interpret results during treatment, and what the optimal range looks like for metabolic health.
Learn how diet, fasting, carbohydrate intake, and postprandial glucose spikes alter GlycoMark (1,5-AG) levels, what the optimal range is, and how to interpret your result in clinical context.
Learn how testosterone, EPO, GLP-1 agonists, and other medications raise or lower hematocrit, what the optimal range is, and when your clinician should act. Evidence-based.
A guide to IGFBP-3 normal ranges, longevity-medicine target ranges, and how this GH-axis biomarker pairs with IGF-1 to guide peptide, GH, and anti-aging protocols.
A decade-by-decade clinical guide to pituitary MRI indications, prolactin and cortisol thresholds, incidentaloma workup, and society guideline recommendations for ordering and interpreting pituitary imaging across the lifespan.
Prolactin runs 2 to 29 ng/mL in premenopausal women, rising up to 40 ng/mL in luteal phase; levels above 25-40 ng/mL need pituitary workup.
What plasma renin activity levels predict cardiovascular and longevity outcomes? A guide to PRA interpretation, conventional reference ranges, and the evidence (and its limits) behind longevity-medicine target ranges.
Reverse T3 (rT3) is a non-functional thyroid metabolite that competes with active T3 at cell receptors. Learn the conventional normal range, the longevity-medicine target range, what drives rT3 elevation, and when treatment is warranted.
A guide to interpreting SHBG (extended) in the context of longevity medicine, including optimal target ranges, interaction with testosterone and estradiol, and what high or low SHBG means for long-term health outcomes.
A decade-by-decade clinical guide to sex hormone-binding globulin (SHBG): what counts as normal, what counts as optimal, and how age, sex, and metabolic health shift the target range.
Sex hormone-binding globulin (SHBG) binds testosterone and estradiol, directly controlling how much of each hormone is biologically active. This HealthRX.com guide covers the clinical reference range, longevity-medicine optimal targets, and how SHBG interacts with TRT, HRT, and metabolic disease.
Learn how fasting, carbohydrate intake, dietary fat, insulin, and specific nutrients drive SHBG up or down, and what the optimal SHBG range looks like for men and women.
A guide to thyroglobulin antibody (TgAb) reference ranges, longevity-medicine targets, thyroid autoimmunity staging, and post-thyroidectomy surveillance, with primary-source citations throughout.
Trimethylamine N-oxide (TMAO) is a gut-derived cardiovascular risk marker with emerging longevity-medicine target ranges. Learn what optimal TMAO looks like, how it is measured, and what clinicians recommend to lower elevated levels.
How aerobic training, resistance exercise, overtraining, and body-composition changes affect TSH levels, what the optimal TSH range looks like for active adults, and when a shifting TSH reading warrants clinical action.
DEXA-derived VAT reference ranges, longevity-medicine targets, and clinical cut-points explained with an evidence-boundary map, sourcing caveats, and a decision framework for interpreting visceral fat results.